Stock CLHO CLEOPATRA HOSPITALS GROUP S.A.E.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cleopatra Hospitals Group S.A.E.

Equities

CLHO

EGS729J1C018

End-of-day quote Egyptian Exchange
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
6.33 EGP -2.91% Intraday chart for Cleopatra Hospitals Group S.A.E. -5.52% +34.11%
Mar. 17 Cleopatra Hospitals Group S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Cleopatra Hospitals Group S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

  • The company appears highly valued given the size of its balance sheet.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
CLEOPATRA HOSPITALS GROUP S.A.E. Stock Cleopatra Hospitals Group S.A.E.
+34.11% 191M
B-
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
B+
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
B+
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
B+
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+23.61% 8.26B
B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.19% 7.68B
A-
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+20.75% 7.2B
D
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
B-
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B -
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
  1. Stock Market
  2. Equities
  3. CLHO Stock
  4. Ratings Cleopatra Hospitals Group S.A.E.